Tripti Singh

[University of Wisconsin Division of Nephrology @uw_nephrology]

We are thrilled to have Dr. @Tripti_neph and Dr. @SarahPanzer representing the Nephrology Division at last week's NKF Rare Disease Roundup!

[Kate Robson @nephrologista]

Lively navigation of rapidly evolving complexity in podocytopathies with @MessiasNidia @LauraMarianiMD @Tripti_neph @womeninnephro @glomcon #GlomConHawaii

[GlomCon @GlomCon]

Clinical trials are the backbone of medical advancements, yet recruitment remains a significant challenge.

This session will explore the various factors contributing to recruitment difficulties, including patient awareness, trial design complexities (control arms and standard of care), and logistical hurdles.

Attendees will learn strategies to enhance recruitment efforts, understand the importance of diverse participant pools, and discuss innovative approaches to overcome common barriers.

Register here 👉 https://t.co/wy6jGmuCve

#GlomConHawaii2024 #GlomCon #nephtwitter #MedTwitter

[Tripti Singh @Tripti_neph]

ASN is about meeting amazing women leaders in nephrology to get inspired @vandyniyyar @VijayanMD

[University of Wisconsin Division of Nephrology @uw_nephrology]

Poster at ASN #KidneyWk by second-year fellow Dr. Angelie Santos and faculty mentor Dr. Tripti Singh: "Preeclampsia or Lupus Nephritis in Pregnancy: The Role of Renal Biopsy" @uw_medicine @SuzanneNorby @Tripti_neph

[University of Wisconsin Division of Nephrology @uw_nephrology]

Dr. Singh presents another poster at ASN #KidneyWk: "Prescribing patterns for Sodium-glucose Cotransporter 2 Inhibitors: a survey of nephrologists" @uw_medicine @Tripti_neph @SuzanneNorby

[Tripti Singh @Tripti_neph]

@uw_nephrology @uw_medicine @FA_Nephrology @WIsimulation Our amazing fellows in action teaching the medical students!

[GlomCon @GlomCon]

We are conducting a study to learn about barriers in prescribing SGLT2i.

We invite nephrologists to participate in this very brief survey 👇

https://t.co/ZcekHTwVA2

Thank you!

[University of Wisconsin Division of Nephrology @uw_nephrology]

Use of SGLT2i <10% in CKD patients: https://t.co/9BEX3uykym

We are conducting a research study to learn about barriers in prescribing SGLT2i. The survey is brief:
https://t.co/ITKxY6eOfq

@uw_medicine @MinZhuo4 @ASNKidney360 @Tripti_neph

[Tripti Singh @Tripti_neph]

@artwalaszek @uw_nephrology @uwsmph @uw_medicine Working with colleagues from other specialities- one of the best parts of my job!!

[Tripti Singh @Tripti_neph]

@hswapnil @uw_nephrology @ssrasm 1K bath in inpatient setting with monitoring and 1-2 treatments seem to be very safe!
Higher mortality in outpatient setting when used for multiple treatments!!